Johnson & Johnson JNJ
i
Market dataready · fetched 2026-11-07T01:55:40.495Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-13
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-07T00:51:27.930185033Z
FundamentalsSEC EDGAR · ready · as of 2026-09-27 · fetched 2026-11-07T01:52:21.076408+00:00
Johnson & Johnson options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 285.12 | 26.6% | 3.7% | 267.21 | 29.0% | 3.6% |
| 25Δ | 283.00 | 25.2% | 3.0% | 269.16 | 28.3% | 3.1% |
| 30Δ | 281.57 | 25.7% | 2.7% | 270.88 | 27.6% | 2.6% |
| 35Δ | 280.36 | 26.7% | 2.4% | 272.47 | 26.8% | 2.2% |
| 40Δ | 279.04 | 26.9% | 2.1% | 273.76 | 27.5% | 1.9% |
| 45Δ | 277.68 | 26.6% | 1.8% | 275.06 | 28.3% | 1.7% |
| 50Δ | 276.38 | 27.0% | 1.6% | 276.41 | 28.2% | 1.5% |
| 55Δ | 275.08 | 27.5% | 1.4% | 277.77 | 28.1% | 1.2% |
| 60Δ | 273.78 | 27.2% | 1.2% | 279.12 | 27.8% | 1.0% |
| 65Δ | 272.48 | 26.8% | 1.0% | 280.67 | 28.3% | 0.8% |
| 70Δ | 271.30 | 25.6% | 0.8% | 282.56 | 30.1% | 0.7% |
| 75Δ | 270.12 | 24.5% | 0.6% | 284.21 | 29.6% | 0.5% |
| 80Δ | 267.94 | 26.5% | 0.5% | 286.65 | 30.9% | 0.4% |
20Δ
- Pseudo strike
- 285.12
- IV
- 26.6%
- B/E move
- 3.7%
- Pseudo strike
- 267.21
- IV
- 29.0%
- B/E move
- 3.6%
25Δ
- Pseudo strike
- 283.00
- IV
- 25.2%
- B/E move
- 3.0%
- Pseudo strike
- 269.16
- IV
- 28.3%
- B/E move
- 3.1%
30Δ
- Pseudo strike
- 281.57
- IV
- 25.7%
- B/E move
- 2.7%
- Pseudo strike
- 270.88
- IV
- 27.6%
- B/E move
- 2.6%
35Δ
- Pseudo strike
- 280.36
- IV
- 26.7%
- B/E move
- 2.4%
- Pseudo strike
- 272.47
- IV
- 26.8%
- B/E move
- 2.2%
40Δ
- Pseudo strike
- 279.04
- IV
- 26.9%
- B/E move
- 2.1%
- Pseudo strike
- 273.76
- IV
- 27.5%
- B/E move
- 1.9%
45Δ
- Pseudo strike
- 277.68
- IV
- 26.6%
- B/E move
- 1.8%
- Pseudo strike
- 275.06
- IV
- 28.3%
- B/E move
- 1.7%
50Δ
- Pseudo strike
- 276.38
- IV
- 27.0%
- B/E move
- 1.6%
- Pseudo strike
- 276.41
- IV
- 28.2%
- B/E move
- 1.5%
55Δ
- Pseudo strike
- 275.08
- IV
- 27.5%
- B/E move
- 1.4%
- Pseudo strike
- 277.77
- IV
- 28.1%
- B/E move
- 1.2%
60Δ
- Pseudo strike
- 273.78
- IV
- 27.2%
- B/E move
- 1.2%
- Pseudo strike
- 279.12
- IV
- 27.8%
- B/E move
- 1.0%
65Δ
- Pseudo strike
- 272.48
- IV
- 26.8%
- B/E move
- 1.0%
- Pseudo strike
- 280.67
- IV
- 28.3%
- B/E move
- 0.8%
70Δ
- Pseudo strike
- 271.30
- IV
- 25.6%
- B/E move
- 0.8%
- Pseudo strike
- 282.56
- IV
- 30.1%
- B/E move
- 0.7%
75Δ
- Pseudo strike
- 270.12
- IV
- 24.5%
- B/E move
- 0.6%
- Pseudo strike
- 284.21
- IV
- 29.6%
- B/E move
- 0.5%
80Δ
- Pseudo strike
- 267.94
- IV
- 26.5%
- B/E move
- 0.5%
- Pseudo strike
- 286.65
- IV
- 30.9%
- B/E move
- 0.4%
Options history
Table
| Date | IV (%) |
|---|---|
| 24.54% | |
| 23.42% | |
| 23.12% | |
| 23.82% | |
| 20.09% | |
| 23.74% | |
| 24.44% | |
| 23.80% | |
| 23.71% | |
| 21.56% | |
| 22.86% | |
| 22.60% | |
| 22.68% | |
| 22.98% | |
| 20.96% | |
| 21.69% | |
| 22.15% | |
| 23.86% | |
| 21.97% | |
| 20.83% | |
| 24.26% | |
| 24.19% | |
| 23.40% | |
| 21.82% | |
| 23.57% | |
| 27.08% | |
| 24.25% | |
| 24.21% | |
| 23.03% | |
| 24.32% | |
| 25.69% | |
| 25.26% | |
| 24.82% | |
| 24.49% | |
| 26.44% | |
| 26.27% | |
| 25.95% | |
| 25.46% | |
| 24.78% | |
| 27.90% | |
| 27.22% | |
| 27.75% | |
| 28.80% | |
| 28.29% | |
| 32.91% | |
| 27.77% | |
| 24.98% | |
| 25.91% | |
| 24.27% | |
| 24.64% | |
| 25.62% | |
| 25.48% | |
| 28.34% | |
| 24.71% | |
| 26.60% | |
| 25.96% | |
| 26.59% | |
| 25.44% | |
| 26.38% |
Drug Manufacturers - General
LLY
Description unavailable
More →MRK
Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in…
More →NVO
Novo Nordisk A / S, a healthcare company, is dedicated to the research, development, manufacture and marketing of pharmaceutical products globally. The company is headquartered in…
More →NVS
Novartis AG researches, develops, manufactures and markets medical devices worldwide. The company is headquartered in Basel, Switzerland.
More →OGN
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine,…
More →PFE
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New York City. The name of the company…
More →